Correlation Between GlaxoSmithKline PLC and Menivim New
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Menivim New at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Menivim New into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Menivim The New, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Menivim New and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Menivim New. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Menivim New.
Diversification Opportunities for GlaxoSmithKline PLC and Menivim New
-0.94 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between GlaxoSmithKline and Menivim is -0.94. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Menivim The New in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Menivim The New and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Menivim New. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Menivim The New has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Menivim New go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and Menivim New
Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Menivim New. But the stock apears to be less risky and, when comparing its historical volatility, GlaxoSmithKline PLC ADR is 1.09 times less risky than Menivim New. The stock trades about -0.31 of its potential returns per unit of risk. The Menivim The New is currently generating about 0.33 of returns per unit of risk over similar time horizon. If you would invest 18,100 in Menivim The New on August 29, 2024 and sell it today you would earn a total of 1,660 from holding Menivim The New or generate 9.17% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 81.82% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. Menivim The New
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| Menivim The New |
GlaxoSmithKline PLC and Menivim New Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and Menivim New
The main advantage of trading using opposite GlaxoSmithKline PLC and Menivim New positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Menivim New can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Menivim New will offset losses from the drop in Menivim New's long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
| Menivim New vs. Sella Real Estate | Menivim New vs. Reit 1 | Menivim New vs. MeguREIT Israel | Menivim New vs. Azrieli Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |